too showed that in NSCLC lacking LKB1 metformin enhances survivin degradation, through inhibition of the protein kinase A (PKA)/glycogen synthase kinase-3β (GSK-3β) axis, mediated by activation of AMPK (70). The gene discussed is STK11; the disease is non-small cell lung carcinoma.